A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

NCT07183293 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HBV-related Liver Cirrhosis

Interventions

DRUG: Peginterferon alfa-2b combined with NAs
DRUG: NAs

Sponsor

Xiamen Humanity Hospital